Antibodies to human serum amyloid P component eliminate visceral amyloid deposits (Q34144814)

31 July 2017

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits (English)

1 reference

31 July 2017

1 reference

20

1 reference

31 July 2017

18

Marina Botto

0 references

Arthur R Bradwell

object named as

Arthur R Bradwell

14

0 references

Andrzej Loesch

5

object named as

Andrzej Loesch

1 reference

31 July 2017

Karl Bodin

1

1 reference

31 July 2017

Stephan Ellmerich

2

1 reference

31 July 2017

Melvyn C Kahan

3

1 reference

31 July 2017

Glenys A Tennent

4

1 reference

31 July 2017

Janet A Gilbertson

6

1 reference

31 July 2017

Winston L Hutchinson

7

1 reference

31 July 2017

Palma P Mangione

8

1 reference

31 July 2017

J Ruth Gallimore

9

1 reference

31 July 2017

David J Millar

10

1 reference

31 July 2017

Shane Minogue

11

1 reference

31 July 2017

Amar P Dhillon

12

1 reference

31 July 2017

Graham W Taylor

13

1 reference

31 July 2017

Aviva Petrie

15

1 reference

31 July 2017

Julian D Gillmore

16

1 reference

31 July 2017

Vittorio Bellotti

17

1 reference

31 July 2017

Marina Botto

18

1 reference

31 July 2017

Philip N Hawkins

19

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 October 2010

1 reference

31 July 2017

1 reference

31 July 2017

468

1 reference

31 July 2017

7320

1 reference

31 July 2017

93-97

1 reference

https://scigraph.springernature.com/pub.10.1038/nature09494

31 July 2017

0 references

cites work

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Natural history and outcome in systemic AA amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Isolation of human C-reactive protein and serum amyloid P component.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Amyloid P-component is a constituent of normal human glomerular basement membrane

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Immunophagocytosis of human amyloid fibrils by leukocytes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

A primed state exists in vivo following histological regression of amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Activation of mouse complement by different classes of mouse antibody

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Binding of serum amyloid P-component (SAP) by amyloid fibrils

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Amyloid P component. A critical review

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE09494

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975378

A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells

28 October 2018

1 reference

12 December 2020

Phagocytosis of dialysis-related amyloid deposits by macrophages

1 reference

12 December 2020

Amyloid P component is located on elastic fibre microfibrils in normal human tissue

1 reference

12 December 2020

Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response

1 reference

12 December 2020

Liposomes for specific depletion of macrophages from organs and tissues

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE09494

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NATURE09494

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference